Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines
Abstract Global vaccination programs using live-attenuated oral and inactivated polio vaccine (OPV and IPV) have almost eradicated poliovirus (PV) but these vaccines or their production pose significant risk in a polio-free world. Recombinant PV virus-like particles (VLPs), lacking the viral genome,...
Main Authors: | Mohammad W. Bahar, Claudine Porta, Helen Fox, Andrew J. Macadam, Elizabeth E. Fry, David I. Stuart |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-01-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-020-00267-3 |
Similar Items
-
Plant-made polio type 3 stabilized VLPs—a candidate synthetic polio vaccine
by: Johanna Marsian, et al.
Published: (2017-08-01) -
Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine.
by: Marsian, J, et al.
Published: (2017) -
New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication.
by: Sarah Knowlson, et al.
Published: (2015-12-01) -
Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals.
by: Yvonne E Thomassen, et al.
Published: (2013-01-01) -
A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation
by: Mohammad W. Bahar, et al.
Published: (2022-11-01)